Approved the Resignation of Sahil Shah from the post of Chief Financial Officer (KMP) of the Company with effect from 29 April 2020.

Approved the Appointment of Chetas Patel as a Chief Financial Officer (KMP) of the Company with effect from 29 April 2020.

The board endorses the company's plan to work on the development of human vaccines, beginning with work on COVID-19 disease vaccine.